Market research of medicinal products which are used in cardiological diseases treatment

Aim of the study is to carry out market research of medicinal products which are used in cardiological diseases treatment. Materials and methods. The products range analysis was performed according to the Ukraine State Register of medicines and classification system of ATC. We have studied the pharm...

Full description

Saved in:
Bibliographic Details
Main Authors: O. S. Kukhtenko (Author), L. S. Simonyan (Author), Ye. V. Hladukh (Author)
Format: Book
Published: Zaporozhye State Medical University, 2017-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2e86be8b975742c29f3826bcc8dea035
042 |a dc 
100 1 0 |a O. S. Kukhtenko  |e author 
700 1 0 |a L. S. Simonyan  |e author 
700 1 0 |a Ye. V. Hladukh  |e author 
245 0 0 |a Market research of medicinal products which are used in cardiological diseases treatment 
260 |b Zaporozhye State Medical University,   |c 2017-08-01T00:00:00Z. 
500 |a 10.14739/2409-2932.2017.2.103783 
500 |a 2306-8094 
500 |a 2409-2932 
520 |a Aim of the study is to carry out market research of medicinal products which are used in cardiological diseases treatment. Materials and methods. The products range analysis was performed according to the Ukraine State Register of medicines and classification system of ATC. We have studied the pharmaceutical market of cardiotonic action drugs (С01 - cardiological medicines, namely C01ЕВ - other cardiological drugs and С01ЕХ - various combined cardiological drugs). It has been determined that the market of cardiological action preparations is characterized by favorable environment for implementation of the new offered product from the point of view of drugs' economic affordability to consumers. Manufacture leaders of this group of preparations of foreign and domestic production have been denoted. Results of the study. The ratio of medicines trade names of foreign and domestic production is 35 % to 65 %, full dominance of domestic medicines is observed. In the period from 2012 to 2016 the supply of domestic products had increased by 37.6 %, and foreign by 18.6 %. Analysis of registered trade names of medicines by manufacturing companies has shown that the main share of the assortment is formed by drugs of European pharmaceutical companies. Conclusions. Тhe development of domestic production of cardiac funds is a positive factor for the development of drugs in this market segment and it indicates the widespread use of this category of drugs among the population of the country. The analysis of dosage forms was conducted, according to which tablets and liquid dosage forms of a combination composition - tinctures and drops - are the most popular among consumers. 
546 |a EN 
546 |a RU 
546 |a UK 
690 |a cardiac disease 
690 |a neurotic disorders 
690 |a drug combinations 
690 |a plant extracts 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, Iss 2, Pp 219-223 (2017) 
787 0 |n http://pharmed.zsmu.edu.ua/article/view/103783/99953 
787 0 |n https://doaj.org/toc/2306-8094 
787 0 |n https://doaj.org/toc/2409-2932 
856 4 1 |u https://doaj.org/article/2e86be8b975742c29f3826bcc8dea035  |z Connect to this object online.